Know Cancer

or
forgot password
  • cancer clinical trials in new brunswick, NJ

  • Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Neuroblastoma
    IGIV Study for Chronic ITP Patients Ages 3-70
    UMDNJ-RWJ Medical School
    New Brunswick, New Jersey 08901
    Idiopathic Thrombocytopenic Purpura
    Second Curettage in Treating Patients With Persistent Non-Metastatic Gestational Trophoblastic Tumor
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Gestational Trophoblastic Tumor
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Neuroblastoma
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Cancer Institute of New Jersey

    Trial Locations
    Cancer Institute of New Jersey
    UMDNJ - Robert Wood Johnson University Hospital
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Metastatic Breast Cancer
    Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
    Cancer Institute of New Jersey

    Trial Locations
    Cancer Institute of New Jersey
    UMDNJ - Robert Wood Johnson University Hospital
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Prostate Cancer
    Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Multimodality Phase II Study in Prostate Cancer
    The Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Prostate Cancer
    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Endometrial Cancer, Fatigue, Neurotoxicity
    Sunitinib and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Chemotherapy
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Malignant Neoplasm
    Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
    UMDNJ - Robert Wood Johnson University Hospital
    New Brunswick, New Jersey 08903
    Adult Rhabdomyosarcoma, Adult Synovial Sarcoma, Childhood Hepatoblastoma, Childhood Synovial Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adrenocortical Carcinoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Neuroblastoma, Recurrent Osteosarcoma, Recurrent Retinoblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Kidney Cancer
    Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Melanoma (Skin)
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia
    Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia, Lymphoma
    Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Estrogen Receptor-negative Breast Cancer, Fallopian Tube Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2), Male Breast Cancer, Primary Peritoneal Cavity Cancer, Progesterone Receptor-negative Breast Cancer, Recurrent Breast Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Pancreatic Cancer, Recurrent Prostate Cancer, Triple-negative Breast Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia, Lymphoma
    Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Leukemia, Lymphoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    Collecting and Storing Biological Samples From Patients With Ewing Sarcoma
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Sarcoma
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Lymphoma
    Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Colorectal Cancer
    Radiation Therapy in Treating Women With Early Stage Breast Cancer
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Hydroxychloroquine + Carboplatin, Paclitaxel and Bevacizumb in Non-Small Cell Lung Cancer (NSCLC)
    Cancer Institute of New Jersey
    New Brunswick, New Jersey 08901
    Non-small Cell Lung Cancer
    Phase I/II Study of Weekly Abraxane and RAD001 in Women With Locally Adv. or Metastatic Breast Ca
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    New Brunswick, New Jersey 08903
    Breast Cancer
    Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
    Umdnj Cinj
    New Brunswick, New Jersey 080903
    Childhood Cancers
    Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
    UMDNJ-Robert Wood Johnson Clinical Research Center UMDNJ-Robert Wood Johnson Med
    New Brunswick, New Jersey 08903
    Myelodysplastic Syndromes
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    UMDNJ - Robert Wood Johnson University Hospital
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Study of Blood Samples From Newborns With Down Syndrome
    Saint Peter's University Hospital

    Trial Locations
    Saint Peter's University Hospital
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
    Leukemia